CVS Global

SoviHep Tablets contain Sofosbuvir as their active ingredient, which is a medication used to treat chronic hepatitis C virus (HCV) infection in adults.
Sofosbuvir is a direct-acting antiviral (DAA) medication that inhibits the HCV NS5B RNA polymerase enzyme, which is essential for the replication of the virus. By inhibiting this enzyme, Sofosbuvir can reduce the amount of HCV in the body, leading to improved liver function and a reduced risk of complications from HCV infection.
SoviHep Tablets are usually taken once a day orally, in combination with other medications such as ribavirin or daclatasvir, depending on the genotype of the HCV infection and other factors.
Normal results of Sofosbuvir might incorporate weakness, cerebral pain, and sickness. It might likewise cause more serious secondary effects, like unfavorably susceptible responses, misery, or liver issues, albeit these are uncommon.

Sofosbuvir should be used with caution in patients with certain medical conditions, such as liver or kidney disease, and may interact with other medications. Always inform your doctor of any medications you are taking before starting Sofosbuvir.
As with all medications, it is important to follow your doctor's instructions and use Sofosbuvir only as prescribed. Do not exceed the recommended dose or use for longer than prescribed, as this can increase the risk of side effects. If you experience any concerning symptoms while taking Sofosbuvir, contact your doctor immediately

Sofosbuvir + Ledipasvir is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is a combination of two antiviral drugs, Sofosbuvir and Ledipasvir.
Sofosbuvir is a nucleotide simple inhibitor that works by obstructing the replication of the HCV infection. Ledipasvir is an immediate acting antiviral specialist that hinders a particular protein in the HCV infection, keeping it from duplicating.
The combination of Sofosbuvir and Ledipasvir has been shown to be highly effective in curing HCV infection, with cure rates exceeding 90% in most cases. It is typically prescribed for a period of 12 weeks, although the duration of treatment may vary depending on the patient's HCV genotype and other medical factors.
Sofosbuvir + Ledipasvir should be taken exactly as prescribed by your doctor, usually once daily with or without food. It is important to complete the full course of treatment as directed, even if you start feeling better before the end of the treatment period.
Common side effects of Sofosbuvir + Ledipasvir may include headache, fatigue, nausea, and diarrhea. More serious side effects may occur, such as severe allergic reactions or liver problems, although these are rare.
If you experience any concerning symptoms while taking Sofosbuvir + Ledipasvir, such as yellowing of the skin or eyes, severe stomach pain, or difficulty breathing, contact your doctor immediately. As with all medications, it is important to inform your doctor of any other medications you are taking before starting treatment with Sofosbuvir + Ledipasvir.

Revolade is a brand name for the prescription eltrombopag. It is a doctor prescribed drug used to treat low platelet includes in grown-ups with persistent resistant thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, or extreme aplastic sickliness who have not answered different therapies.
Eltrombopag works by stimulating the production of platelets in the bone marrow, which helps to increase the number of platelets in the blood. This can help to prevent bleeding episodes in people with low platelet counts.
Revolade tablets are usually taken once a day, with or without food, and the dose is adjusted based on the individual's platelet count. It is important to follow the dosing instructions provided by your healthcare provider.
Common side effects of Revolade may include nausea, diarrhea, headache, and fatigue. In rare cases, eltrombopag may cause more serious side effects such as liver problems, blood clots, and decreased bone marrow function.
Revolade should only be used under the supervision of a healthcare provider and is not recommended for people with a history of blood clots or liver disease. It is important to inform your healthcare provider if you are pregnant, breastfeeding, or have any other medical conditions before using this medication.

Tavin LN kit is a combination medication used for the treatment of human immunodeficiency virus (HIV) infection. It contains three different drugs: Lamivudine, Tenofovir Alafenamide, and Dolutegravir. This medication works by blocking the activity of the virus and reducing the amount of virus in the body, which helps to improve the immune system and prevent further damage. Tavin LN kit is available only with a doctor's prescription and should be used under the supervision of a healthcare professional.

Myhep Tablets is a combination medication that contains Sofosbuvir and Velpatasvir.It is utilized to treat persistent hepatitis C infection (HCV) disease in grown-ups.
Sofosbuvir is a HCV NS5B polymerase inhibitor, while Velpatasvir is a HCV NS5A inhibitor.Together, they work to inhibit the replication of HCV in the body.
Myhep Tablets is typically taken orally, once a day, with or without food, as directed by a healthcare provider. The length of treatment might fluctuate relying upon the singular patient and the genotype of the HCV disease.
Normal results of Myhep Tablets might incorporate cerebral pain, weakness, queasiness, the runs, and sleep deprivation. More serious side effects, such as allergic reactions or liver problems, are rare but require immediate medical attention.
It is important to discuss any medical conditions or medications you are taking with your healthcare provider before starting treatment with Myhep Tablets or any other medication for HCV infection.Also, this medicine might communicate with different drugs, for example, those for HIV, that might influence its adequacy or increment the gamble of secondary effects.

Resof L Tablet is a medication used to treat chronic hepatitis C virus (HCV) infection. It is a combination medication that contains two active ingredients: Sofosbuvir and Ledipasvir. Sofosbuvir is an antiviral medication that works by inhibiting the HCV polymerase enzyme, which is essential for the replication of the virus. Ledipasvir is also an antiviral medication that works by inhibiting the HCV NS5A protein, which is another essential component for HCV replication.
The mix of Sofosbuvir and Ledipasvir in Resof L Tablet has been demonstrated to be viable in treating a few genotypes of HCV. It is typically required once per day for a time of 12 to 24 weeks, contingent upon the seriousness of the disease and the patient's clinical history.
It is important to inform your healthcare provider if you are taking any other medications or supplements, as they may interact with Resof L Tablet. Some common side effects of Resof L Tablet may include fatigue, headache, nausea, diarrhea, and insomnia. In rare cases, Resof L Tablet may cause serious side effects such as severe allergic reactions, liver problems, and bradycardia (slow heart rate).
Resof L Tablet should only be taken under the supervision of a healthcare provider, and it is important to follow the dosage and administration instructions carefully. It should not be used during pregnancy or breastfeeding without consulting a healthcare provider

Velasof is a medicine used to treat ongoing hepatitis C infection (HCV) disease in grown-ups. It contains a mix of two dynamic fixings: velpatasvir and sofosbuvir. Velpatasvir and sofosbuvir cooperate to restrain the replication of HCV in the body, permitting the resistant framework to clear the infection.

Velasof is usually taken orally once a day with or without food, as directed by a doctor. The duration of treatment varies depending on the genotype of the HCV infection and the patient's individual needs. It is important to take the medication regularly and at the same time each day to achieve the best results.
Common side effects of Velasof include headache, fatigue, nausea, and diarrhea. In some cases, more serious side effects such as allergic reactions, liver problems, and heart problems may occur. Patients taking Velasof should notify their doctor immediately if they experience any concerning symptoms.
Velasof should not be taken by individuals who are allergic to velpatasvir, sofosbuvir, or any of the other ingredients in the medication. It may also interact with other medications, so it is important to inform a doctor of all medications being taken before starting treatment with Velasof.
Overall, Velasof is an important medication for the treatment of chronic HCV infection, but it should only be used under the supervision of a qualified healthcare professional.

Ledifos is a combination medication that contains two active ingredients: Ledipasvir and Sofosbuvir. It is used to treat chronic hepatitis C virus (HCV) infection in adults. Ledipasvir and Sofosbuvir work by targeting specific proteins and enzymes that are essential for the replication of HCV, thereby preventing the virus from multiplying and spreading in the body.
Ledifos is usually taken orally in tablet form, and the dosage and duration of treatment may vary depending on the individual's condition and response to treatment.It is essential to accept Ledifos as endorsed by a medical care supplier and to adhere to a particular guidelines with respect to eat less and liquid admission.
Like all prescriptions, Ledifos might cause aftereffects, including weariness, migraine, sickness, and loose bowels. It is important to report any side effects to a healthcare provider, as some may be serious and require medical attention.
Ledifos is a prescription medication, and it is important to talk to a healthcare provider before starting or stopping any medication. It might collaborate with different prescriptions or ailments, and it may not be reasonable for everybody.

Hepcvir L Tablet is an antiviral medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is manufactured by Cipla Limited, an Indian pharmaceutical company. The dynamic fixings in Hepcvir L Tablet are Sofosbuvir and Ledipasvir.

Sofosbuvir and Ledipasvir are both antiviral medications that work by interfering with the reproduction of the hepatitis C virus in the body.  Sofosbuvir is a nucleotide simple inhibitor that prevents the infection from imitating, while Ledipasvir is a NS5A inhibitor that keeps the infection from collecting and delivering new popular particles.
Hepcvir L Tablets are regularly required orally once every day with nourishment for a span of 12 to 24 weeks, contingent upon the patient's clinical history, genotype of the hepatitis C infection, and different variables. It's important to take Hepcvir L Tablets as directed by a healthcare professional and to complete the full course of treatment, even if symptoms improve.
Like all medications, Hepcvir L Tablets may cause side effects, although not everyone will experience them. Some common side effects of Hepcvir L Tablets may include headache, fatigue, nausea, diarrhea, and insomnia.More serious incidental effects are intriguing, yet may incorporate liver issues, heart issues, and hypersensitive responses.
In the event that you are thinking about taking Hepcvir L Tablets or have been recommended this drug, examining the advantages and dangers with an authorized medical care professional is fundamental. Your healthcare provider can provide guidance on the appropriate dosage and duration of treatment and can monitor your progress to ensure that the medication is working effectively and that you are not experiencing any side effects.